JPRN-UMIN000030568招募中未知
Efficacy and safety of etelcalcetide in hemodialysis patients with secondary hyperparathyroidism inadequately controlled with cinacalcet - SWITCH Study
Jinken Clinic0 个研究点目标入组 20 人开始时间: 2017年12月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Corrected serum calcium <8.4 mg/dL Receiving hemodialysis less than three months
研究者
相似试验
招募中
不适用
The safety and efficacy of etelcalcetide for the treatment of secondary hyperparathyroidism compared with cinacalcetPatients on maintenance hemodialysis treated with cinacalcet for secondary hyperparathyroidismJPRN-UMIN000028041Matsunami general hospital20
招募中
不适用
The safety and efficacy of etelcalcetide for the treatment of secondary hyperparathyroidism compared with cinacalcetPatients on maintenance hemodialysis treated with cinacalcet for secondary hyperparathyroidismJPRN-UMIN000027344Matsunami general hospital10
已完成
不适用
Evaluation of calcimimetic therapy in hemodialysis patients with secondary hyperparathyroidism: a real-world observational studyHemodialysis patients with secondary hyperparathyroidismJPRN-UMIN000030354Ono Pharmaceutical Co.,ltd.3,000
已完成
不适用
Efficacy of Etelcalcetide vs Cinacalcet in Hemodialyzed Patients with Secondary HyperparathyroidismSecondary HyperparathyroidismJPRN-UMIN000034155Saitama Sekishinkai Hospital50
已完成
不适用
Investigation of the clinical effect of hemodialysis using electrolyzed waterrenal failure requiring hemodialysis (HD)JPRN-UMIN000025113ephrology, Osaka National Hospital, NHO40